Display options
Cite
Gill J, Cashion A, Osier N, et al. Moderate blast exposure alters gene expression and levels of amyloid precursor protein. Neurol Genet. 2017;3(5):e186doi: 10.1212/NXG.0000000000000186.
Gill, J., Cashion, A., Osier, N., Arcurio, L., Motamedi, V., Dell, K. C., Carr, W., Kim, H. S., Yun, S., Walker, P., Ahlers, S., LoPresti, M., & Yarnell, A. (2017). Moderate blast exposure alters gene expression and levels of amyloid precursor protein. Neurology. Genetics, 3(5), e186. https://doi.org/10.1212/NXG.0000000000000186
Gill, Jessica, et al. "Moderate blast exposure alters gene expression and levels of amyloid precursor protein." Neurology. Genetics vol. 3,5 (2017): e186. doi: https://doi.org/10.1212/NXG.0000000000000186
Gill J, Cashion A, Osier N, Arcurio L, Motamedi V, Dell KC, Carr W, Kim HS, Yun S, Walker P, Ahlers S, LoPresti M, Yarnell A. Moderate blast exposure alters gene expression and levels of amyloid precursor protein. Neurol Genet. 2017 Sep 27;3(5):e186. doi: 10.1212/NXG.0000000000000186. eCollection 2017 Oct. PMID: 28975156; PMCID: PMC5618107.
Copy Download .nbib Format: NLM
Share it on

Neurol Genet. 2017 Sep 27;3(5):e186. doi: 10.1212/NXG.0000000000000186. eCollection 2017 Oct.

Moderate blast exposure alters gene expression and levels of amyloid precursor protein.

Neurology. Genetics

Jessica Gill, Ann Cashion, Nicole Osier, Lindsay Arcurio, Vida Motamedi, Kristine C Dell, Walter Carr, Hyung-Suk Kim, Sijung Yun, Peter Walker, Stephen Ahlers, Matthew LoPresti, Angela Yarnell

Affiliations

  1. Intramural Research Program, CNRM Co Director Biomarkers Core, Uniformed Services University of the Health Sciences (J.G.) and National Institute of Nursing Research (A.C., N.O., L.A., V.M., H.-S.K., S.Y.), National Institutes of Health, Bethesda; Walter Reed Army Institute of Research (K.C.D., M.L., A.Y.), Silver Spring; Army Medical Research and Materiel Command (W.C.), Fort Detrick; and Naval Medical Research Center (P.W., S.A.), Silver Spring, MD.

PMID: 28975156 PMCID: PMC5618107 DOI: 10.1212/NXG.0000000000000186

Abstract

OBJECTIVE: To explore gene expression after moderate blast exposure (vs baseline) and proteomic changes after moderate- (vs low-) blast exposure.

METHODS: Military personnel (N = 69) donated blood for quantification of protein level, and peak pressure exposures were detected by helmet sensors before and during a blast training program (10 days total). On day 7, some participants (n = 29) sustained a moderate blast (mean peak pressure = 7.9 psi) and were matched to participants with no/low-blast exposure during the training (n = 40). PAXgene tubes were collected from one training site at baseline and day 10; RNA-sequencing day 10 expression was compared with each participant's own baseline samples to identify genes and pathways differentially expressed in moderate blast-exposed participants. Changes in amyloid precursor protein (APP) from baseline to the day of blast and following 2 days were evaluated. Symptoms were assessed using a self-reported form.

RESULTS: We identified 1,803 differentially expressed genes after moderate blast exposure; the most altered network was APP. Significantly reduced levels of peripheral APP were detected the day after the moderate blast exposure and the following day. Protein concentrations correlated with the magnitude of the moderate blast exposure on days 8 and 9. APP concentrations returned to baseline levels 3 days following the blast, likely due to increases in the genetic expression of APP. Onset of concentration problems and headaches occurred after moderate blast.

CONCLUSIONS: Moderate blast exposure results in a signature biological profile that includes acute APP reductions, followed by genetic expression increases and normalization of APP levels; these changes likely influence neuronal recovery.

References

  1. PLoS One. 2016 Jul 18;11(7):e0158576 - PubMed
  2. Neurosci Lett. 1993 Oct 1;160(2):139-44 - PubMed
  3. Aging Dis. 2016 Mar 15;7(2):163-79 - PubMed
  4. J Gerontol A Biol Sci Med Sci. 1998 May;53(3):B186-90 - PubMed
  5. Exp Neurol. 2015 Sep;271:53-71 - PubMed
  6. Neurology. 2000 Oct 24;55(8):1158-66 - PubMed
  7. Front Neurol. 2012 Dec 21;3:177 - PubMed
  8. J Neurosci. 1994 Apr;14(4):2117-27 - PubMed
  9. Behav Brain Res. 2016 Aug 31;:null - PubMed
  10. Lancet. 1994 Oct 15;344(8929):1055-6 - PubMed
  11. Front Neurol. 2015 Mar 16;6:49 - PubMed
  12. J Int Neuropsychol Soc. 2011 Jan;17(1):36-45 - PubMed
  13. Neurology. 2001 Dec 26;57(12):2243-8 - PubMed
  14. Am J Med Genet B Neuropsychiatr Genet. 2003 Apr 1;118B(1):99-102 - PubMed
  15. J Head Trauma Rehabil. 2010 Jan-Feb;25(1):9-14 - PubMed
  16. Acta Neuropathol Commun. 2014 Nov 25;2:153 - PubMed
  17. Free Radic Biol Med. 2014 Apr;69:331-7 - PubMed
  18. Front Neurol. 2014 Oct 09;5:198 - PubMed
  19. Exp Brain Res. 2012 Apr;217(3-4):471-9 - PubMed
  20. Bioinformatics. 2014 Feb 15;30(4):523-30 - PubMed
  21. J Neurotrauma. 2013 Aug 15;30(16):1391-7 - PubMed
  22. J Neurosci Rural Pract. 2015 Oct-Dec;6(4):481-7 - PubMed
  23. J Steroid Biochem Mol Biol. 2014 Oct;144 Pt B:280-5 - PubMed
  24. J Neurotrauma. 2017 Feb 15;34(4):853-860 - PubMed
  25. J Clin Neurosci. 2000 Mar;7(2):140-5 - PubMed
  26. NMR Biomed. 2015 Sep;28(9):1069-77 - PubMed

Publication Types